Mayo Clinic: Endometrial Neoplasms trials

The registry lists 19 Endometrial Neoplasms studies with Mayo Clinic as lead sponsor. 11 are open to participants now and 3 have results posted.

Early Phase 1 1Phase 1 5Phase 2 4Phase 4 1No phase 10(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Flyte Device for Improving Urinary Incontinence Among Endometrial and Cervical Cancer Survivors Who Have Undergone Radiation TherapyRecruitingNCT07662824Not applicable
• Acceptability of Testing DNA Markers in Vaginal Fluid for the Detection of Endometrial CancerRecruitingNCT07527143
• Screening and Staging of Benign vs Malignant Pelvic AbnormalitiesRecruitingNCT07407959
• The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding AreasRecruitingNCT07285044Phase 2
• Low Dose Aspirin to Lower Inflammation and Prevent Endometrial Cancer in Postmenopausal Women With Non-atrophic Endometrial Changes and PainNot yet recruitingNCT07281547Phase 4
• Molecular and ctDNA Characterization of High-Risk Endometrial CancerRecruitingNCT07062016
• Non-Invasive Identification of Endometrial Cancer/Endometrial Atypical Hyperplasia With an AI-Based Classifier Applied to Transvaginal Ultrasound in Patients With Post-Menopausal BleedingRecruitingNCT06365905
• Immune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic PlatformRecruitingNCT06349642
• Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid TumorsRecruitingNCT05269381Phase 1/2
• Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical CancerRecruitingNCT05051722
• Comparison of Proton or Intensity Modulated Radiation Therapy After Surgery for Endometrial or Cervical CancerRecruitingNCT04567771Not applicable
• VSV-hIFNbeta-NIS With or Without Ruxolitinib Phosphate in Treating Stage IV or Recurrent Endometrial CancerActive, not recruitingNCT03120624Phase 1Results posted
• Positron Emission Tomography (PET) Imaging Studies With NIS ReporterTerminatedNCT02907073Phase 1/2Results posted
• Ribociclib and Letrozole in Treating Patients With Relapsed ER Positive Ovarian, Fallopian Tube, Primary Peritoneal, or Endometrial CancerCompletedNCT02657928Phase 2Results posted
• Targeting Inflammation for Endometrial Cancer PreventionActive, not recruitingNCT05407025
• Development of a New Early Detection Test to Reduce Racial Disparities in Endometrial Cancer (EC) Death RatesCompletedNCT04474184Phase 1
• F-18 TFB-PET Studies in Cancer Patients Undergoing NIS-containing Viral TherapiesCompletedNCT03456908Phase 1
• Efficacy of PET/MRI in Detecting Metastatic Disease in Endometrial CancerTerminatedNCT02765698
• Nanoparticle Albumin-Bound Rapamycin in Treating Patients With Advanced Cancer With mTOR MutationsCompletedNCT02646319Early Phase 1